tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Mirum Pharmaceuticals assumed with a Buy at H.C. Wainwright
PremiumThe FlyMirum Pharmaceuticals assumed with a Buy at H.C. Wainwright
2M ago
Mirum Pharmaceuticals price target raised to $77 from $73 at Raymond James
Premium
The Fly
Mirum Pharmaceuticals price target raised to $77 from $73 at Raymond James
3M ago
Buy Rating on Mirum Pharmaceuticals: Promising Phase 2b VANTAGE Study Results and Strong Market Potential
Premium
Ratings
Buy Rating on Mirum Pharmaceuticals: Promising Phase 2b VANTAGE Study Results and Strong Market Potential
3M ago
Mirum Pharmaceuticals Reports Strong Q1 2025 Results
PremiumCompany AnnouncementsMirum Pharmaceuticals Reports Strong Q1 2025 Results
3M ago
Mirum Pharmaceuticals reports Q1 EPS (30c), consensus (27c)
Premium
The Fly
Mirum Pharmaceuticals reports Q1 EPS (30c), consensus (27c)
3M ago
Mirum Pharmaceuticals receives FDA approval for Livmarli tablet formulation
Premium
The Fly
Mirum Pharmaceuticals receives FDA approval for Livmarli tablet formulation
4M ago
Mirum Pharmaceuticals’ Earnings Call Highlights Growth and Future Prospects
PremiumCompany AnnouncementsMirum Pharmaceuticals’ Earnings Call Highlights Growth and Future Prospects
5M ago
Mirum Pharmaceuticals price target raised to $65 from $63 at Morgan Stanley
Premium
The Fly
Mirum Pharmaceuticals price target raised to $65 from $63 at Morgan Stanley
5M ago
Mirum Pharmaceuticals price target raised to $55 from $50 at Baird
Premium
The Fly
Mirum Pharmaceuticals price target raised to $55 from $50 at Baird
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100